The data analysis demonstrated that higher expression of SMYD2 is present in a variety of human cancers, like breast, bladder, colorectal, cervical, esophageal, lymphoma, ovarian, head and neck, and pancreatic cancer [14, 16, 22]. This evidence concerns the gene SMYD2 and lymphoma.